News | August 22, 2013

American Society of Nuclear Cardiology Launches New Online Education Activity on Reducing Radiation Exposure

August 22, 2013 — The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.

“Patient-Centered Imaging: Strategies for Reducing Radiation Dose Levels in Nuclear Cardiology Studies” is an interactive case-based online CME/CE activity designed to increase learners’ competence on the appropriateness of cardiac imaging testing and the rationale for reducing exposure to ionizing radiation in adults who are at risk for coronary artery disease. The activity is a valuable guide for healthcare professionals, including hospital practice administrators, who are involved in the field of nuclear cardiology.

The objectives of the program are for participants, upon completion of this online educational activity, to be able to:

  • Demonstrate the importance of using appropriate use criteria to select the nuclear imaging tests and radiopharmaceuticals that will result in the lowest possible dose of radiation;
  • Review factors that influence use of radiation exposure (age, medical condition, etc.); and
  • Demonstrate techniques, technologies, software applications and acquisition parameters that will reduce radiation exposure.


The program faculty includes ASNC’s current president, James A. Arrighi, M.D., FASNC (Rhode Island Hospital/Alpert Medical School of Brown University), and vice president, Brian G. Abbott, M.D., FASNC (Rhode Island Cardiology Center/Alpert Medical School of Brown University). Additional faculty includes Gordon DePuey, M.D., FASNC; April Mann, CNMT, RT(N), NCT, FASNC; Leslee J. Shaw, Ph.D., FASNC; Kim A. Williams, Sr., M.D., FASNC; and Jack A. Ziffer, M.D., Ph.D., FASNC.

For more information: http://www.asnc.org/content_15364.cfm

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...